Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial

OBJECTIVE: Evaluate the efficacy, safety, and tolerability of zavegepant nasal spray in the acute treatment of migraine. BACKGROUND: Calcitonin gene‐related peptide‐targeting agents are a novel class of therapeutics for migraine, but none are currently available as a nonoral option for acute treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Croop, Robert, Madonia, Jennifer, Stock, David A., Thiry, Alexandra, Forshaw, Micaela, Murphy, Abigail, Coric, Vladimir, Lipton, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827820/
https://www.ncbi.nlm.nih.gov/pubmed/36239038
http://dx.doi.org/10.1111/head.14389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827820/
https://www.ncbi.nlm.nih.gov/pubmed/36239038
http://dx.doi.org/10.1111/head.14389

Ejemplares similares